Gilden Photonics has inked a $1.54 million agreement with a life-sciences company, to produce a system that utilizes light to evaluate bodily fluids for identifying abnormalities.
Gilden Photonics has also contributed in establishing the first Hyperspectral imaging center, in the year beginning, at the University of Strathclyde. The establishment of the imaging center was co-sponsored by the Bridging the Gap Initiative of the university. The center will offer a central location, providing the hyperspectral imaging basic technology to all researchers and businesses in Scotland.
Gilden Photonics’ Sales Director, Kevin Lynch stated that the company has made the technology available economically so that many industries could use it for measuring and identifying materials. He added that the technology could be utilized for assistance in crime detection and homeland defence, for testing the quality of drink and food, and for detecting tooth decay without using x-rays or drilling.